Close Menu

NEW YORK – The US Food and Drug Administration on Tuesday issued Emergency Use Authorization for LumiraDx's rapid antigen test for SARS-CoV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.